In this translational research proposal we test the hypothesis that healing of chronic cutaneous wounds may be enhanced by grafting of temporary human skin substitutes generated from human keratinocytes which have been genetically engineered to enhance vascularization of the underlying wound bed. Two strategies to achieve this goal are described, I.) tissue-specific expression of the angiogenic growth factor VEGF-165 and II.) tissue-specific expression of a constitutively active transcription, factor hypoxia-inducible factor-1alpha (HIF-1a). HIF-1a is a universal regulator of cellular and systemic oxygen homeostasis and is overexpressed during wound healing. HIF is known to upregulate the expression of a number of target genes including those involved in vasculogenesis. We generated genetically engineered human keratinocyte cell lines ex vivo that constitutively produce VEGF-165 and active HIF-1a protein in a tissue-specific manner regardless of oxygen tension. Using tissue engineering strategies these keratinocyte cell lines will be used to produce biologically active human skin substitutes to investigate the physiological and/or pathological consequences of persistent epidermal angiogenic signaling on vascularization and wound healing. The revised aims are:
Specific Aim 1. Isolate stable NIKS keratinocyte lines (NIKS(Empty Vector) , NIKS(VEGF165), NIKS(HIF-1alpha/ODD), NIKS(HIF-1alpha)).Verify that monolayer cultures of these new NIKS cell lines produce and secrete enhanced levels of biologically active angiogenic proteins.
Specific Aim 2. Produce human skin substitutes using genetically engineered NIKS(Empty Vector), NIKS(VEGF-165), NIKS(HIF-1alpha), and NIKS(HIF-1alpha/ODD) keratinocytes and analyze for target gene expression and angiogenic protein production. Analyze the histological features of genetically engineered tissues by immunohistochemistry. Determine HIF-1a target gene expression by in situ hybridization and quantitative PCR. Confirm enhanced levels of biologically active angiogenic proteins using quantitative assays.
Specific Aim 3. Determine the effects of constitutive, epidermal angiogenic signaling on wound healing, physiological and pathological vessel production, organization, and function using human skin substitute tissue xenografts generated from NIKS, NIKS(Empty Vector), NlKS(VEGF-165) , NlKS(HIF-1a), and NIKS(HIF-1a/ODD) cell lines.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL074284-04
Application #
7394448
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Lundberg, Martha
Project Start
2005-04-01
Project End
2011-03-31
Budget Start
2008-04-01
Budget End
2011-03-31
Support Year
4
Fiscal Year
2008
Total Cost
$334,474
Indirect Cost
Name
University of Wisconsin Madison
Department
Public Health & Prev Medicine
Type
Schools of Earth Sciences/Natur
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
De Abrew, K Nadira; Thomas-Virnig, Christina L; Rasmussen, Cathy A et al. (2014) TCDD induces dermal accumulation of keratinocyte-derived matrix metalloproteinase-10 in an organotypic model of human skin. Toxicol Appl Pharmacol 276:171-8
Gibson, Angela L; Thomas-Virnig, Christina L; Centanni, John M et al. (2012) Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds. Wound Repair Regen 20:414-24
Centanni, John M; Straseski, Joely A; Wicks, April et al. (2011) StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. Ann Surg 253:672-83
Gill, Erin M; Straseski, Joely A; Rasmussen, Cathy A et al. (2010) Visualization of morphological and molecular features associated with chronic ischemia in bioengineered human skin. Microsc Microanal 16:117-31
Rasmussen, Cathy A; Gibson, Angela L; Schlosser, Sandy J et al. (2010) Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration. Ann Surg 251:368-76
Straseski, Joely A; Gibson, Angela L; Thomas-Virnig, Christina L et al. (2009) Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen. Wound Repair Regen 17:606-16
Schurr, Michael J; Foster, Kevin N; Centanni, John M et al. (2009) Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute. J Trauma 66:866-73; discussion 873-4
Gibson, Angela L; Schurr, Michael J; Schlosser, Sandy J et al. (2008) Comparison of therapeutic antibiotic treatments on tissue-engineered human skin substitutes. Tissue Eng Part A 14:629-38
Slavik, Marni A; Allen-Hoffmann, B Lynn; Liu, Bob Y et al. (2007) Wnt signaling induces differentiation of progenitor cells in organotypic keratinocyte cultures. BMC Dev Biol 7:9